You need JavaScript to view this

Validation of quantitative brain dopamine D2 receptor imaging with a conventional single-head SPET camera

Abstract

Phantom measurements were performed with a conventional single-head single-photon emission tomography (SPET) camera in order to validate the relevance of the basal ganglia/frontal cortex iodine-123 iodobenzamide (IBZM) uptake ratios measured in patients. Inside a cylindrical phantom (diameter 22 cm), two cylinders with a diameter of 3.3 cm were inserted. The activity concentrations of the cylinders ranged from 6.0 to 22.6 kBq/ml and the cylinder/background activity ratios varied from 1.4 to 3.8. From reconstructed SPET images the cylinder/background activity ratios were calculated using three different regions of interest (ROIs). A linear relationship between the measured activity ratio and the true activity ratio was obtained. In patient studies, basal ganglia/frontal cortex IBZM uptake ratios determined from the reconstructed slices using attentuation correction prior to reconstruction were 1.30 [+-]0.03 in idiopathic Parkinson's disease (n = 9), 1,33 [+-]0.09 in infantile and juvenile neuronal ceroid lipofuscinosis (n = 7) and 1.34 [+-]0.05 in narcolepsy (n = 8). Patients with Huntington's disease had significantly lower ratios (1.09 [+-]0.04, n = 5). The corrected basal ganglia/frontal cortex ratios, determined using linear regression, were about 80 % higher. The use of dual-window scatter correction increased the measured ratios by about 10 %. Although comprehensive correction methods can  More>>
Authors:
Nikkinen, P; [1]  Liewendahl, K; [1]  Savolainen, S; [2]  Launes, J [3] 
  1. Helsinki Univ. (Finland). Dept. of Clinical Chemistry
  2. Helsinki Univ. (Finland). Dept. of Physics
  3. Helsinki Univ. (Finland). Dept. of Neurology
Publication Date:
Aug 01, 1993
Product Type:
Journal Article
Reference Number:
DEN-93-0FC707; EDB-93-160497
Resource Relation:
Journal Name: European Journal of Nuclear Medicine; (Germany); Journal Volume: 20:8
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; BRAIN; RECEPTORS; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; CORRECTIONS; GAMMA CAMERAS; DOPAMINE; GANGLIONS; IODINE 123; NERVOUS SYSTEM DISEASES; PATIENTS; PHANTOMS; RADIOPHARMACEUTICALS; UPTAKE; VALIDATION; AMINES; AROMATICS; AUTONOMIC NERVOUS SYSTEM AGENTS; BETA DECAY RADIOISOTOPES; BODY; CAMERAS; CARDIOTONICS; CARDIOVASCULAR AGENTS; CENTRAL NERVOUS SYSTEM; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DISEASES; DRUGS; ELECTRON CAPTURE RADIOISOTOPES; EMISSION COMPUTED TOMOGRAPHY; HOURS LIVING RADIOISOTOPES; HYDROXY COMPOUNDS; INTERMEDIATE MASS NUCLEI; IODINE ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; MEMBRANE PROTEINS; MOCKUP; NERVOUS SYSTEM; NEUROREGULATORS; NUCLEI; ODD-EVEN NUCLEI; ORGANIC COMPOUNDS; ORGANS; PHENOLS; POLYPHENOLS; PROTEINS; RADIOISOTOPES; STRUCTURAL MODELS; SYMPATHOMIMETICS; TESTING; TOMOGRAPHY; 550601* - Medicine- Unsealed Radionuclides in Diagnostics
OSTI ID:
5775439
Country of Origin:
Germany
Language:
English
Other Identifying Numbers:
Journal ID: ISSN 0340-6997; CODEN: EJNMD9
Submitting Site:
DEN
Size:
Pages: 680-683
Announcement Date:
Dec 15, 1993

Citation Formats

Nikkinen, P, Liewendahl, K, Savolainen, S, and Launes, J. Validation of quantitative brain dopamine D2 receptor imaging with a conventional single-head SPET camera. Germany: N. p., 1993. Web.
Nikkinen, P, Liewendahl, K, Savolainen, S, & Launes, J. Validation of quantitative brain dopamine D2 receptor imaging with a conventional single-head SPET camera. Germany.
Nikkinen, P, Liewendahl, K, Savolainen, S, and Launes, J. 1993. "Validation of quantitative brain dopamine D2 receptor imaging with a conventional single-head SPET camera." Germany.
@misc{etde_5775439,
title = {Validation of quantitative brain dopamine D2 receptor imaging with a conventional single-head SPET camera}
author = {Nikkinen, P, Liewendahl, K, Savolainen, S, and Launes, J}
abstractNote = {Phantom measurements were performed with a conventional single-head single-photon emission tomography (SPET) camera in order to validate the relevance of the basal ganglia/frontal cortex iodine-123 iodobenzamide (IBZM) uptake ratios measured in patients. Inside a cylindrical phantom (diameter 22 cm), two cylinders with a diameter of 3.3 cm were inserted. The activity concentrations of the cylinders ranged from 6.0 to 22.6 kBq/ml and the cylinder/background activity ratios varied from 1.4 to 3.8. From reconstructed SPET images the cylinder/background activity ratios were calculated using three different regions of interest (ROIs). A linear relationship between the measured activity ratio and the true activity ratio was obtained. In patient studies, basal ganglia/frontal cortex IBZM uptake ratios determined from the reconstructed slices using attentuation correction prior to reconstruction were 1.30 [+-]0.03 in idiopathic Parkinson's disease (n = 9), 1,33 [+-]0.09 in infantile and juvenile neuronal ceroid lipofuscinosis (n = 7) and 1.34 [+-]0.05 in narcolepsy (n = 8). Patients with Huntington's disease had significantly lower ratios (1.09 [+-]0.04, n = 5). The corrected basal ganglia/frontal cortex ratios, determined using linear regression, were about 80 % higher. The use of dual-window scatter correction increased the measured ratios by about 10 %. Although comprehensive correction methods can further improve the resolution in SPET images, the resolution of the SPET system used by us (1.5 - 2 cm) will determine what is achievable in basal ganglia D2 receptor imaging. (orig.)}
journal = []
volume = {20:8}
journal type = {AC}
place = {Germany}
year = {1993}
month = {Aug}
}